99% Lidocaine Hydrochloride Powder CAS 73-78-9 For Local Anesthetics
You are here: Home » Products » Pharmaceutical Raw Material » 99% Lidocaine Hydrochloride Powder CAS 73-78-9 For Local Anesthetics

loading

99% Lidocaine Hydrochloride Powder CAS 73-78-9 For Local Anesthetics 99% Lidocaine Hydrochloride Powder CAS 73-78-9 For Local Anesthetics
99% Lidocaine Hydrochloride Powder CAS 73-78-9 For Local Anesthetics 99% Lidocaine Hydrochloride Powder CAS 73-78-9 For Local Anesthetics
99% Lidocaine Hydrochloride Powder CAS 73-78-9 For Local Anesthetics 99% Lidocaine Hydrochloride Powder CAS 73-78-9 For Local Anesthetics

99% Lidocaine Hydrochloride Powder CAS 73-78-9 For Local Anesthetics

Availability:
Quantity:
  • 73-78-9

  • HOYAN

99% High Quality Lidocaine Hydrochloride Powder CAS 73-78-9 For Local Anesthetics
Product Description

Contact me: grace@whhoyan.com

Whats app/ Signal/ Skype: 0086 15832900195

Threema: AH8F6N9P


Common Name Lidocaine hydrochloride
CAS Number 73-78-9 Molecular Weight 270.798
Density N/A Boiling Point 350.8ºC at 760 mmHg
Molecular Formula C14H23ClN2O Melting Point 80-82°C


Use of Lidocaine hydrochloride

Lidocaine Hcl salt, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo, possibly due to an attenuation of pro-inflammatory cytokines, intracellular adhesion molecule-1 (ICAM-1), and reduction of neutrophils influx.


Target: Lidocaine is a common local anesthetic and antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning and pain from skin inflammations, injected as a dental anesthetic or as a local anesthetic for minor surgery. 


Lidocaine, the first amino amide–type local anesthetic, was first synthesized under the name xylocaine by Swedish chemist Nils Lofgren in 1943. His colleague Bengt Lundqvist performed the first injection anesthesia experiments on himself.


Lidocaine is approximately 95% metabolized (dealkylated) in the liver by CYP3A4 to the pharmacologically-active metabolites monoethylglycinexylidide (MEGX) and then subsequently to the inactive glycine xylidide. MEGX has a longer half life than lidocaine but also is a less potent sodium channel blocker. The elimination half-life of lidocaine is approximately 90–120 minutes in most patients. This may be prolonged in patients with hepatic impairment (average 343 minutes) or congestive heart failure (average 136 minutes).


lidocaine powder best price (2)

pinterest sharing button
facebook sharing button
twitter sharing button
wechat sharing button
linkedin sharing button
whatsapp sharing button
sharethis sharing button
Previous: 
Next: 
Hoyan Pharmaceutical (Wuhan) Co., Ltd. is a scientific and technological company integrating R&D, production and trade of chemical intermediates.

QUICK LINKS

PRODUCT CATEGORY

CONTACT US

 Hoyan Pharmaceutical (Wuhan) Co., Ltd.
 +86-19831381159
 +86-27-82339698
Copyright  2023 Hoyan Pharmaceutical (Wuhan) Co., Ltd. SitemapPrivacy Policy